Skip to content

Clinical trials

Phase 1 Asthma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Asthma Phase: Phase 1 Country / region: China Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20181
20191
20202
20217
20224
20235
20242
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Unknown status4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline2
Jiangsu HengRui Medicine Co., Ltd.2
Keymed Biosciences Co.Ltd2
Mabwell (Shanghai) Bioscience Co., Ltd.2
Shanghai Hengrui Pharmaceutical Co., Ltd.2
Anhui Palo Alto Pharmaceuticals, Inc.1
Bio-Thera Solutions1
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.1
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.1
Genrix (Shanghai) Biopharmaceutical Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Asthma27
Pulmonary Disease, Chronic Obstructive4
Dermatitis, Atopic3
Disease1
Inflammatory Bowel Diseases1
Pulmonary Eosinophilia1
Rhinitis, Allergic1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.